Strides Pharma Science surged 6.35% to Rs 899.85 after the company reported a consolidated net profit of Rs 10.37 crore in Q4 FY24 as against a net loss of Rs 13.8 crore posted in Q4 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
